Keywords: ucb, keppra, oked, europe, epilepsy, pharma, belgium

UCB's Keppra OKed in Europe for epilepsy

Article | 05 October 2000

Print This

UCB Pharma of Belgium has revealed that it has been granted a license bythe European Commission to market its anti-epileptic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in